Protective effects of geniposide against Tripterygium glycosides (TG)-induced liver injury and its mechanisms
-
- Wang Junming
- Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Henan University of Traditional Chinese Medicine, China College of Pharmacy, Henan University of Traditional Chinese Medicine, China
-
- Miao Mingsan
- Third-Grade Pharmacology Laboratory of State Administration of Traditional Chinese Medicine, Henan University of Traditional Chinese Medicine, China
-
- Qu Lingbo
- College of Chemistry and Molecular Engineering, Zhengzhou University, China
-
- Cui Ying
- Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Henan University of Traditional Chinese Medicine, China College of Pharmacy, Henan University of Traditional Chinese Medicine, China
-
- Zhang Yueyue
- Collaborative Innovation Center for Respiratory Disease Diagnosis and Treatment & Chinese Medicine Development of Henan Province, Henan University of Traditional Chinese Medicine, China College of Pharmacy, Henan University of Traditional Chinese Medicine, China
書誌事項
- タイトル別名
-
- Protective effects of geniposide against <i>Tripterygium</i> glycosides (TG)-induced liver injury and its mechanisms
この論文をさがす
抄録
Tripterygium glycosides (TG) are commonly used for basic medicine in curing rheumatoid arthritis but with a high incidence of liver injury. Geniposide (GP) has broad and diverse bioactivities, but until now it is still unknown whether GP can protect against TG-induced liver injury. This study, for the first time, observed the possible protection of GP against TG-induced liver injury in mice and its mechanisms underlying. Oral administration of TG (270 mg/kg) induced significant elevation in the levels of serum alanine / aspartate transaminase (ALT/AST), hepatic malondialdehyde (MDA) and pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-α) (all P < 0.01). On the other hand, remarkably decreased biomarkers, including hepatic glutathione (GSH) level, activities of glutathione transferase (GST), glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT), and anti-inflammatory cytokine interleukin (IL)-10, were observed following TG exposure (all P < 0.01). Nevertheless, all of these phenotypes were evidently reversed by pre-administration of GP for 7 continuous days. Further analysis showed that the mRNA expression of hepatic growth factor-beta1 (TGF-β1), one of tissue repair and regeneration cytokines, was enhanced by GP. Taken together, the current research suggests that GP protects against TG-induced liver injury in mice probably involved during attenuating oxidative stress and inflammation, and promoting tissue repair and regeneration.
収録刊行物
-
- The Journal of Toxicological Sciences
-
The Journal of Toxicological Sciences 41 (1), 165-173, 2016
一般社団法人 日本毒性学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204905556736
-
- NII論文ID
- 130005119792
-
- NII書誌ID
- AN00002808
-
- ISSN
- 18803989
- 03881350
-
- NDL書誌ID
- 027114587
-
- PubMed
- 26763404
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可